查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1450286

胸腔血管覆膜支架市场:现况分析与预测（2023-2030）

Thoracic Vascular Stent Graft Market: Current Analysis and Forecast (2023-2030)
出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 156 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

胸部血管支架移植物是一种特殊类型的血管内支架移植物，旨在支撑和加强胸部薄弱或受损的动脉壁。 使用微创技术将支架移植物插入受影响的血管，通常是经由腹股沟的动脉，并引导至主动脉的目标部位。 一旦支架移植物就位，它就会扩张以创建新的血流路径，从而将血液从受影响的区域转移出去，并降低破裂和其他併发症的风险。 由于多种因素，胸部血管覆膜支架市场正在快速成长。 首先，主动脉疾病的盛行率不断上升，特别是在人口老化中，刺激了对有效治疗方案的需求。 此外，微创技术的进步使这些手术对患者来说更容易、更安全，进一步推动市场成长。 例如，根据美国疾病管制与预防中心的数据，大约 2% 的美国人患有瓣膜性心臟病。

2022 年，胸腔血管覆膜支架市值为 2.5 亿美元，预估 2023 年至 2030 年复合年增长率约为 6%。

依产品划分，市场分为塑胶胸腔血管支架移植物及金属胸腔血管支架移植物。 近年来，金属胸腔覆膜支架的需求不断增加。 这些专用医疗器材广泛用于治疗胸主动脉瘤和其他涉及胸主动脉的疾病。 金属胸腔覆膜支架的需求增加是由于多种因素造成的。 首先，医疗和外科技术的进步提高了这些设备的安全性和有效性，使它们成为许多医疗保健专业人员的首选。

依最终用户划分，市场分为医院、门诊手术中心等。 其中，医院类别将在2022年占据较大市场。 这主要是由于医院进行了大量的治疗，并且在这种环境下拥有先进的医疗设备和专业知识。

为了更了解该产业的市场实施情况，我们根据其在北美、欧洲、亚太地区和世界其他地区的全球分布对市场进行了分析。 到2022年，北美将在胸血管覆膜支架市场占据压倒性。 北美完善的医疗基础设施、不断上涨的医疗成本和不断增加的血管疾病病例是推动北美市场成长的主要因素。

市场上营运的主要公司包括 Medtronic、Artivion, Inc、Cook Medical、MicroPort Scientific Corporation、Terumo Corporation、Gore Medical、Lamed、Cordis、Vascumed (Pty) Ltd、LeMaitre Vascular, Inc.。

目录

第1章市场介绍

  • 市场定义
  • 主要目标
  • 利害关係人
  • 限制

第2章研究方法或前提

  • 调查过程
  • 调查方法
  • 受访者简介

第3章市场总结

第 4 章执行摘要

第5章全球胸血管覆膜支架市场

第6章 COVID-19 对市场的影响

第7章全球胸腔血管覆膜支架市场收入（2020-2030）

第 8 章市场洞察：按产品

  • 塑胶胸腔血管支架移植物
  • 金属胸腔血管覆膜支架

第 9 章市场洞察：最终用户

  • 医院
  • 门诊手术中心
  • 其他

第 10 章市场洞察：按地区

  • 北美
    • 美国
    • 加拿大
    • 北美其他地区
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 亚太地区其他地区
  • 世界其他地区

第11章胸腔血管覆膜支架市场动态

  • 市场驱动因素
  • 市场挑战
  • 影响分析

第12章胸腔血管覆膜支架市场机会

第13章胸血管覆膜支架市场趋势

第14章需求面与供给面分析

  • 需求方分析
  • 供给面分析

第 15 章价值链分析

第16章竞争场景

  • 竞争状况
    • 波特五力分析

第17章公司简介

  • Medtronic
  • Artivion, Inc
  • Cook medical
  • MicroPort Scientific Corporation
  • Terumo Corporation
  • Gore Medical
  • Lamed.
  • Cordis
  • Vascumed（Pty）Ltd
  • LeMaitre Vascular, Inc.

第18章 免责事项

简介目录
Product Code: UMHE212620

A thoracic vascular stent graft is a specialized type of endovascular stent graft that is designed to provide support and reinforce the weakened or damaged arterial walls in the thoracic region. It is inserted into the affected blood vessel using minimally invasive techniques, typically through an artery in the groin, and then guided to the target site in the aorta. Once in position, the stent graft expands and forms a new pathway for blood flow, thereby diverting it away from the diseased area and reducing the risk of rupture or other complications. The market for thoracic vascular stent grafts has been rapidly growing due to several factors. Firstly, the increasing prevalence of aortic diseases, particularly in the aging population, has fueled the demand for effective treatment options. Additionally, advancements in minimally invasive techniques have made these procedures more accessible and safer for patients, further driving market growth. For Instance, as per the data of the Centre of Disease Control and Prevention, about 2% of the US Population has valvular disease.

The Thoracic Vascular Stent Graft Market was valued at USD 250 Million in 2022 and is expected to grow at a CAGR of around 6% from 2023-2030.

Based on the product, the market is segmented into plastic thoracic vascular stent grafts and metal thoracic vascular stent grafts. Metal thoracic stent grafts have been experiencing an increasing demand in recent years. These specialized medical devices are widely used in the treatment of thoracic aortic aneurysms and other disorders involving the thoracic aorta. The growing demand for metal thoracic stent grafts can be attributed to several factors. Firstly, advancements in medical technologies and surgical techniques have improved the safety and efficacy of these devices, making them a preferred choice for many healthcare professionals.

On the basis of end-users, the market is categorized into Hospitals, ambulatory surgical centers, and Others. Among these, the hospital's category held a significant share of the market in 2022. This is mainly due to the high volume of treatments performed in hospitals, as well as the availability of advanced medical equipment and expertise in this setting.

For a better understanding of the market adoption of the industry, the market is analyzed based on its worldwide presence in countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, UK, France, Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia-Pacific), Rest of World. North America held dominating share of Thoracic Vascular Stent Graft Market in 2022. The presence of well-established healthcare infrastructure, along with the increasing healthcare expenditure and rising cases of vascular disorders in the countries is the major attributing factor for the market growth in North America.

Some of the major players operating in the market include Medtronic, Artivion, Inc, Cook medical, MicroPort Scientific Corporation, Terumo Corporation, Gore Medical, Lamed, Cordis, Vascumed (Pty) Ltd, LeMaitre Vascular, Inc. etc.

TABLE OF CONTENTS

1. MARKET INTRODUCTION

  • 1.1.Market Definitions
  • 1.2.Main Objective
  • 1.3.Stakeholders
  • 1.4.Limitation

2. RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1.Research Process of the Thoracic Vascular Stent Graft Market
  • 2.2.Research Methodology of the Thoracic Vascular Stent Graft Market
  • 2.3.Respondent Profile

3. MARKET SYNOPSIS

4. EXECUTIVE SUMMARY

5. GLOBAL THORACIC VASCULAR STENT GRAFT MARKET

6. MARKET COVID-19 IMPACT

7. GLOBAL THORACIC VASCULAR STENT GRAFT MARKET REVENUE, 2020-2030F

8. MARKET INSIGHTS BY PRODUCT

  • 8.1.Plastic Thoracic Vascular Stent Grafts
  • 8.2.Metal Thoracic Vascular Stent Grafts

9. MARKET INSIGHTS BY END USER

  • 9.1.Hospitals
  • 9.2.Ambulatory Surgical Centres
  • 9.3.Others

10. MARKET INSIGHTS BY REGION

  • 10.1.North America Thoracic Vascular Stent Graft Market
    • 10.1.1.U.S.
    • 10.1.2.Canada
    • 10.1.3.Rest of North America
  • 10.2.Europe Thoracic Vascular Stent Graft Market
    • 10.2.1.Germany
    • 10.2.2.UK
    • 10.2.3.France
    • 10.2.4.Italy
    • 10.2.5.Spain
    • 10.2.6.Rest of Europe
  • 10.3.Asia-Pacific Thoracic Vascular Stent Graft Market
    • 10.3.1.China
    • 10.3.2.Japan
    • 10.3.3.India
    • 10.3.4.Rest of APAC
  • 10.4.Rest of the World Thoracic Vascular Stent Graft Market

11. THORACIC VASCULAR STENT GRAFT MARKET DYNAMICS

  • 11.1.Market Drivers
  • 11.2.Market Challenges
  • 11.3.Impact Analysis

12. THORACIC VASCULAR STENT GRAFT MARKET OPPORTUNITIES

13. THORACIC VASCULAR STENT GRAFT MARKET TRENDS

14. DEMAND AND SUPPLY-SIDE ANALYSIS

  • 14.1.Demand Side Analysis
  • 14.2.Supply Side Analysis

15. VALUE CHAIN ANALYSIS

16. COMPETITIVE SCENARIO

  • 16.1.Competitive Landscape
    • 16.1.1.Porters Fiver Forces Analysis

17. COMPANY PROFILED

  • 17.1.Medtronic
  • 17.2.Artivion, Inc
  • 17.3.Cook medical
  • 17.4.MicroPort Scientific Corporation
  • 17.5.Terumo Corporation
  • 17.6.Gore Medical
  • 17.7.Lamed.
  • 17.8.Cordis
  • 17.9.Vascumed (Pty) Ltd
  • 17.10.LeMaitre Vascular, Inc.

18. DISCLAIMER